{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:09:29Z","timestamp":1793909369924,"version":"4.8.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007052","name":"Universit\u00e0 degli Studi di Verona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007052","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human cancers, due to its late clinical presentation, early vascular, perineural, nodal and distant dissemination, and profound resistance to systemic therapies. Histologically, conventional PDAC is characterized by infiltrative gland-forming, mucin-producing neoplastic epithelium embedded in a dense desmoplastic stroma. However, recent advances have highlighted substantial morphological, molecular, and microenvironmental heterogeneity. In this review, the clinicopathological and molecular features of conventional PDAC and its recognized histological subtypes have been summarized, integrating the major updates introduced in the latest edition of the\n                    <jats:italic>World Health Organization Classification of Tumours<\/jats:italic>\n                    . Particular emphasis is placed on diagnostic histopathological hallmarks, grading criteria, morphological patterns, and clinically relevant subtypes. They include adenosquamous, colloid, medullary, hepatoid, poorly cohesive\/signet-ring cell, and undifferentiated carcinoma, and undifferentiated carcinoma with osteoclast-like giant cells. The biological basis of PDAC aggressiveness, including vascular and perineural invasion, stromal remodeling, early metastatic spread, immunosuppressive microenvironment, and the central role of classic genetic drivers, namely\n                    <jats:italic>KRAS<\/jats:italic>\n                    ,\n                    <jats:italic>CDKN2A<\/jats:italic>\n                    ,\n                    <jats:italic>TP53<\/jats:italic>\n                    and\n                    <jats:italic>SMAD4<\/jats:italic>\n                    , are presented and discussed. Emerging issues include the reclassification of micropapillary morphology, the expanding differential diagnosis of hepatoid differentiation, the recognition of distinctive precursor and invasive lesions, and the unresolved challenge of assessing treatment response after neoadjuvant therapy. Lastly, a discussion regarding the future perspectives for pancreatic pathology in the era of precision oncology is provided, highlighting the need for integrated histological, molecular, spatial, and immunological approaches to improve diagnostic reproducibility, biomarker discovery, therapeutic stratification and, ultimately, patient outcomes.\n                  <\/jats:p>","DOI":"10.1007\/s00428-026-04681-1","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T05:16:45Z","timestamp":1787375805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pancreatic ductal adenocarcinoma and its subtypes: clinical relevance of histopathology and molecular characterization, integrating the key updates of the 2026 WHO classification"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4901-4908","authenticated-orcid":false,"given":"Claudio","family":"Luchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"4681_CR1","volume-title":"Digestive system tumours","author":"WHO Classification of Tumours Editorial Board","year":"2026","unstructured":"WHO Classification of Tumours Editorial Board (2026) Digestive system tumours. International Agency for Research on Cancer, Lyon. https:\/\/tumourclassification.iarc.who.int\/chapters\/72"},{"key":"4681_CR2","doi-asserted-by":"publisher","first-page":"116963","DOI":"10.1016\/j.amjsurg.2026.116963","volume":"257","author":"MVSR Rami Reddy","year":"2026","unstructured":"Rami Reddy MVSR, Pulvender P, Wood J, Tang J (2026) The impact of tumor location in pancreatic cancer: Survival outcomes after resection in a multi-institutional TriNetX analysis. Am J Surg 257:116963. https:\/\/doi.org\/10.1016\/j.amjsurg.2026.116963","journal-title":"Am J Surg"},{"key":"4681_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41572-026-00699-6","volume":"12","author":"S Roth","year":"2026","unstructured":"Roth S, Apte M, Balachandran VP, Biffi G, Conroy T, Cukierman E, Dotan E, Esposito I, Gr\u00fcnwald BT, Klau\u00df M, Klein AP, Malats N, Reilly O, Pishvaian EM, Real MJ, Saur FX, Siveke D, Michalski JT CW (2026) Pancreatic cancer. Nat Rev Dis Primers 12:23. https:\/\/doi.org\/10.1038\/s41572-026-00699-6","journal-title":"Nat Rev Dis Primers"},{"key":"4681_CR4","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1158\/2159-8290.CD-25-2014","volume":"16","author":"FO Balogun","year":"2026","unstructured":"Balogun FO, Sherman MH, Park W, Soares KC, Reyngold M, Schoenfeld JD, Singhal A, Iacobuzio-Donahue CA, O\u2019Reilly EM (2026) Pancreatic Cancer: Translating Tumor Biology into Actionability. Cancer Discov 16:1262\u20131279. https:\/\/doi.org\/10.1158\/2159-8290.CD-25-2014","journal-title":"Cancer Discov"},{"key":"4681_CR5","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.2741\/2880","volume":"13","author":"H Kitagawa","year":"2008","unstructured":"Kitagawa H, Ohta T, Makino I, Tani T, Tajima H, Nakagawara H, Ohnishi I, Takamura H, Kayahara M, Watanabe H, Gabata T, Matsui O, Zen Y (2008) Carcinomas of the ventral and dorsal pancreas exhibit different patterns of lymphatic spread. Front Biosci 13:2728\u20132735. https:\/\/doi.org\/10.2741\/2880","journal-title":"Front Biosci"},{"key":"4681_CR6","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70043","author":"RL Siegel","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A (2026) Cancer statistics, 2026. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.70043","journal-title":"CA Cancer J Clin"},{"key":"4681_CR7","doi-asserted-by":"publisher","unstructured":"O\u2019Reilly EM, Wainberg ZA, Hendifar AE, Borad MJ, Pietrantonio F, Pant S, Hammel P, Cremolini C, Manji GA, Oberstein PE, Garrido-Laguna I, Springfeld C, Azad NS, Ueno M, Chui SY, Zhang Y, Patel H, Lee Y, Salman Z, Wolpin BM RASolute 302 Trial Investigators (2026) Daraxonrasib or chemotherapy in previously treated metastatic pancreatic Cancer. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2605555","DOI":"10.1056\/NEJMoa2605555"},{"key":"4681_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800685","author":"RH Hruban","year":"2007","unstructured":"Hruban RH, Fukushima N (2007) Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanINs. Mod Pathol. https:\/\/doi.org\/10.1038\/modpathol.3800685","journal-title":"Mod Pathol"},{"key":"4681_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/mpa.0b013e31805d0190","volume":"35","author":"I Esposito","year":"2007","unstructured":"Esposito I, Seiler C, Bergmann F, Kleeff J, Friess H, Schirmacher P (2007) Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment. Pancreas 35:212\u2013217. https:\/\/doi.org\/10.1097\/mpa.0b013e31805d0190","journal-title":"Pancreas"},{"key":"4681_CR10","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A (2023) Pancreatic cancer: Advances and challenges. Cell 186:1729\u20131754. https:\/\/doi.org\/10.1016\/j.cell.2023.02.014","journal-title":"Cell"},{"key":"4681_CR11","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","volume":"39","author":"O Basturk","year":"2015","unstructured":"Basturk O, Hong SM, Wood LD, Adsay NV, Albores-Saavedra J, Biankin AV, Brosens LA, Fukushima N, Goggins M, Hruban RH, Kato Y, Klimstra DS, Kl\u00f6ppel G, Krasinskas A, Longnecker DS, Matthaei H, Offerhaus GJ, Shimizu M, Takaori K, Terris B, Yachida S, Esposito I, Furukawa T, Baltimore Consensus Meeting (2015) A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Am J Surg Pathol 39:1730\u20131741. https:\/\/doi.org\/10.1097\/PAS.0000000000000533","journal-title":"Am J Surg Pathol"},{"key":"4681_CR12","doi-asserted-by":"publisher","first-page":"7773","DOI":"10.1093\/nar\/16.16.7773","volume":"16","author":"VT Smit","year":"1988","unstructured":"Smit VT, Boot AJ, Smits AM, Fleuren GJ, Cornelisse CJ, Bos JL (1988) KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 16:7773\u20137782. https:\/\/doi.org\/10.1093\/nar\/16.16.7773","journal-title":"Nucleic Acids Res"},{"key":"4681_CR13","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/bjc.1991.467","volume":"64","author":"CM Barton","year":"1991","unstructured":"Barton CM, Staddon SL, Hughes CM, Hall PA, O\u2019Sullivan C, Kl\u00f6ppel G, Theis B, Russell RC, Neoptolemos J, Williamson RC et al (1991) Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer 64:1076\u20131082. https:\/\/doi.org\/10.1038\/bjc.1991.467","journal-title":"Br J Cancer"},{"key":"4681_CR14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1126\/science.271.5247.350","volume":"271","author":"SA Hahn","year":"1996","unstructured":"Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350\u2013353. https:\/\/doi.org\/10.1126\/science.271.5247.350","journal-title":"Science"},{"key":"4681_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ng0994-27","volume":"8","author":"C Caldas","year":"1994","unstructured":"Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8:27\u201332. https:\/\/doi.org\/10.1038\/ng0994-27","journal-title":"Nat Genet"},{"key":"4681_CR16","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1164368","volume":"321","author":"S Jones","year":"2008","unstructured":"Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR et al (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801\u20131806. https:\/\/doi.org\/10.1126\/science.1164368","journal-title":"Science"},{"key":"4681_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, Quinn MC, Robertson AJ, Fadlullah MZ, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E et al (2015) Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518:495\u2013501. https:\/\/doi.org\/10.1038\/nature14169","journal-title":"Nature"},{"key":"4681_CR18","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1172\/JCI59227","volume":"122","author":"MA Collins","year":"2012","unstructured":"Collins MA, Bednar F, Zhang Y, Brisset JC, Galb\u00e1n S, Galb\u00e1n CJ, Rakshit S, Flannagan KS, Adsay NV, Pasca di Magliano M (2012) Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. J Clin Invest 122:639\u201353. https:\/\/doi.org\/10.1172\/JCI59227","journal-title":"J Clin Invest"},{"key":"4681_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/path.3017","volume":"226","author":"M Aichler","year":"2012","unstructured":"Aichler M, Seiler C, Tost M, Siveke J, Mazur PK, Da Silva-Buttkus P, Bartsch DK, Langer P, Chiblak S, D\u00fcrr A, H\u00f6fler H, Kl\u00f6ppel G, M\u00fcller-Decker K, Brielmeier M, Esposito I (2012) Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. J Pathol 226:723\u201334. https:\/\/doi.org\/10.1002\/path.3017","journal-title":"J Pathol"},{"key":"4681_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2026.07.015","volume":"18","author":"H Matsumoto","year":"2026","unstructured":"Matsumoto H, Mizuno K, Kondo C, Kawashima H, Hibi H, Ando Y (2026) Clinical characteristics and therapeutic implications of MTAP deletion in pancreatic cancer: a nationwide genomic analysis. Pancreatology 18:S1424-3903(26)00255-3. https:\/\/doi.org\/10.1016\/j.pan.2026.07.015","journal-title":"Pancreatology"},{"key":"4681_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.path.2016.05.003","volume":"9","author":"C Luchini","year":"2016","unstructured":"Luchini C, Capelli P, Scarpa A (2016) Pancreatic ductal adenocarcinoma and its variants. Surg Pathol Clin 9:547\u2013560. https:\/\/doi.org\/10.1016\/j.path.2016.05.003","journal-title":"Surg Pathol Clin"},{"key":"4681_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/path.5260","volume":"248","author":"RH Hruban","year":"2019","unstructured":"Hruban RH, Gaida MM, Thompson E, Hong SM, No\u00eb M, Brosens LA, Jongepier M, Offerhaus GJA, Wood LD (2019) Why is pancreatic cancer so deadly? The pathologist\u2019s view. J Pathol 248:131\u2013141. https:\/\/doi.org\/10.1002\/path.5260","journal-title":"J Pathol"},{"key":"4681_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.32074\/1591-951X-167","volume":"112","author":"C Luchini","year":"2020","unstructured":"Luchini C, Grillo F, Fassan M, Vanoli A, Capelli P, Paolino G, Ingravallo G, Renzulli G, Doglioni C, D\u2019Amuri A, Mattiolo P, Pecori S, Parente P, Florena AM, Zamboni G, Scarpa A (2020) Malignant epithelial\/exocrine tumors of the pancreas. Pathologica 112:210\u2013226. https:\/\/doi.org\/10.32074\/1591-951X-167","journal-title":"Pathologica"},{"key":"4681_CR24","doi-asserted-by":"publisher","first-page":"13833","DOI":"10.3748\/wjg.v20.i38.13833","volume":"20","author":"I Esposito","year":"2014","unstructured":"Esposito I, Konukiewitz B, Schlitter AM, Kl\u00f6ppel G (2014) Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments. World J Gastroenterol 20:13833\u201313841. https:\/\/doi.org\/10.3748\/wjg.v20.i38.13833","journal-title":"World J Gastroenterol"},{"key":"4681_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-026-04531-0","author":"K Behensk\u00e1","year":"2026","unstructured":"Behensk\u00e1 K, Daum O, Daumov\u00e1 M, Bouchner L, Chud\u00e1\u010dek Z, Pintov\u00e1 J, Van\u011b\u010dek T, Mart\u00ednek P, Mezencev R, Farcas M, \u0160vajdler M (2026) Diagnostic utility of targeted next-generation sequencing in indeterminate pancreaticobiliary cytology and small biopsy specimens: a prospective cohort study. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-026-04531-0","journal-title":"Virchows Arch"},{"key":"4681_CR26","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2023-0426-RA","author":"C Luchini","year":"2025","unstructured":"Luchini C (2025) Diagnostic pearls and pitfalls in the evaluation of biopsies of the pancreas. Arch Pathol Lab Med. https:\/\/doi.org\/10.5858\/arpa.2023-0426-RA","journal-title":"Arch Pathol Lab Med"},{"key":"4681_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/PAS.0b013e3182376e36","volume":"36","author":"SM Hong","year":"2012","unstructured":"Hong SM, Goggins M, Wolfgang CL, Schulick RD, Edil BH, Cameron JL, Handra-Luca A, Herman JM, Hruban RH (2012) Vascular invasion in infiltrating ductal adenocarcinoma of the pancreas can mimic pancreatic intraepithelial neoplasia: a histopathologic study of 209 cases. Am J Surg Pathol 36:235\u2013241. https:\/\/doi.org\/10.1097\/PAS.0b013e3182376e36","journal-title":"Am J Surg Pathol"},{"key":"4681_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242571","author":"J Shin","year":"2020","unstructured":"Shin J, Wood LD, Hruban RH, Hong SM (2020) Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0242571","journal-title":"PLoS One"},{"key":"4681_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/mpa.0b013e3180619677","volume":"35","author":"M Kayahara","year":"2007","unstructured":"Kayahara M, Nakagawara H, Kitagawa H, Ohta T (2007) The nature of neural invasion by pancreatic cancer. Pancreas 35:218\u2013223. https:\/\/doi.org\/10.1097\/mpa.0b013e3180619677","journal-title":"Pancreas"},{"key":"4681_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14082616","volume":"14","author":"M De Pastena","year":"2025","unstructured":"De Pastena M, Zingaretti CC, Paiella S, Lionetto G, Guerriero M, De Santis N, Luchini C, Malleo G, Salvia R (2025) Positive lymph nodes independently affect long-term survival after pancreaticoduodenectomy for non-ampullary duodenal adenocarcinoma: a single-center, retrospective analysis. J Clin Med 14:2616. https:\/\/doi.org\/10.3390\/jcm14082616","journal-title":"J Clin Med"},{"key":"4681_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/MPA.0000000000001194","volume":"48","author":"C Luchini","year":"2019","unstructured":"Luchini C, Veronese N, Nottegar A, Riva G, Pilati C, Mafficini A, Stubbs B, Simbolo M, Mombello A, Corbo V, Cheng L, Yachida S, Wood LD, Lawlor RT, Salvia R, Scarpa A (2019) Perineural invasion is a strong prognostic moderator in ampulla of vater carcinoma: a meta-analysis. Pancreas 48:70\u201376. https:\/\/doi.org\/10.1097\/MPA.0000000000001194","journal-title":"Pancreas"},{"key":"4681_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217699","volume":"622","author":"K Br\u00e4utigam","year":"2025","unstructured":"Br\u00e4utigam K, Skok K, Szymonski K, Rift CV, Karamitopoulou E (2025) Tumor immune microenvironment in pancreatic ductal adenocarcinoma revisited - exploring the \u201cspace.\u201d Cancer Lett 622:217699. https:\/\/doi.org\/10.1016\/j.canlet.2025.217699","journal-title":"Cancer Lett"},{"key":"4681_CR33","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1158\/1078-0432.CCR-17-3401","volume":"24","author":"M Wartenberg","year":"2018","unstructured":"Wartenberg M, Cibin S, Zlobec I, Vassella E, Eppenberger-Castori S, Terracciano L, Eichmann MD, Worni M, Gloor B, Perren A, Karamitopoulou E (2018) Integrated genomic and immunophenotypic classification of pancreatic cancer reveals three distinct subtypes with prognostic\/predictive significance. Clin Cancer Res 24:4444\u20134454. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3401","journal-title":"Clin Cancer Res"},{"key":"4681_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/MEG.0000000000000520","volume":"28","author":"C Luchini","year":"2016","unstructured":"Luchini C, Veronese N, Pea A, Sergi G, Manzato E, Nottegar A, Solmi M, Capelli P, Scarpa A (2016) Extranodal extension in N1-adenocarcinoma of the pancreas and papilla of Vater: a systematic review and meta-analysis of its prognostic significance. Eur J Gastroenterol Hepatol 28:205\u20139. https:\/\/doi.org\/10.1097\/MEG.0000000000000520","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4681_CR35","volume-title":"Digestive system tumours","author":"WHO Classification of Tumours Editorial Board","year":"2019","unstructured":"WHO Classification of Tumours Editorial Board (2019) Digestive system tumours. International Agency for Research on Cancer, Lyon"},{"key":"4681_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep41064","volume":"7","author":"AM Schlitter","year":"2017","unstructured":"Schlitter AM, Segler A, Steiger K, Michalski CW, J\u00e4ger C, Konukiewitz B, Pfarr N, Endris V, Bettstetter M, Kong B, Regel I, Kleeff J, Kl\u00f6ppel G, Esposito I (2017) Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): identification of prognostic subtypes. Sci Rep 7:41064. https:\/\/doi.org\/10.1038\/srep41064","journal-title":"Sci Rep"},{"key":"4681_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/bjs\/znac350","volume":"110","author":"BV Janssen","year":"2022","unstructured":"Janssen BV, van Roessel S, van Dieren S, de Boer O, Adsay V, Basturk O, Brosens L, Campbell F, Chatterjee D, Chou A, Doglioni C, Esposito I et al (2022) Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1). Br J Surg 110:67\u201375. https:\/\/doi.org\/10.1093\/bjs\/znac350","journal-title":"Br J Surg"},{"key":"4681_CR38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/bjs\/znaa031","volume":"108","author":"S van Roessel","year":"2021","unstructured":"van Roessel S, Janssen BV, Soer EC, Fari\u00f1a Sarasqueta A, Verbeke CS, Luchini C, Brosens LAA, Verheij J, Besselink MG (2021) Scoring of tumour response after neoadjuvant therapy in resected pancreatic cancer: systematic review. Br J Surg 108:119\u2013127. https:\/\/doi.org\/10.1093\/bjs\/znaa031","journal-title":"Br J Surg"},{"key":"4681_CR39","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/PAS.0000000000001853","volume":"46","author":"H Wang","year":"2022","unstructured":"Wang H, Chetty R, Hosseini M, Allende DS, Esposito I, Matsuda Y, Deshpande V, Shi J, Dhall D, Jang KT, Kim GE, Luchini C, Graham RP, Reid MD, Basturk O, Hruban RH, Krasinskas A, Klimstra DS, Adsay V, Pancreatobiliary Pathology Society (2022) Pathologic examination of pancreatic specimens resected for treated pancreatic ductal adenocarcinoma: recommendations from the Pancreatobiliary Pathology Society. Am J Surg Pathol 46:754\u2013764. https:\/\/doi.org\/10.1097\/PAS.0000000000001853","journal-title":"Am J Surg Pathol"},{"key":"4681_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.humpath.2022.05.018","volume":"127","author":"SJ Kim","year":"2022","unstructured":"Kim SJ, Choi SJ, Yang J, Kim D, Kim DW, Byun JH, Hong SM (2022) Pancreatic ductal adenocarcinoma with a predominant large duct pattern has better recurrence-free survival than conventional pancreatic ductal adenocarcinoma: a comprehensive histopathological, immunohistochemical, and mutational study. Hum Pathol 127:39\u201349. https:\/\/doi.org\/10.1016\/j.humpath.2022.05.018","journal-title":"Hum Pathol"},{"key":"4681_CR41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3892\/ol.2021.12786","volume":"22","author":"H Ryota","year":"2021","unstructured":"Ryota H, Ishida M, Ebisu Y, Yanagimoto H, Yamamoto T, Kosaka H, Hirooka S, Yamaki S, Kotsuka M, Matsui Y, Tsuta K, Satoi S (2021) Clinicopathological characteristics of pancreatic ductal adenocarcinoma with invasive micropapillary carcinoma component with emphasis on the usefulness of PKC\u03b6 immunostaining for detection of reverse polarity. Oncol Lett 22:525. https:\/\/doi.org\/10.3892\/ol.2021.12786","journal-title":"Oncol Lett"},{"key":"4681_CR42","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/modpathol.3800460","volume":"18","author":"S Khayyata","year":"2005","unstructured":"Khayyata S, Basturk O, Adsay NV (2005) Invasive micropapillary carcinomas of the ampullo-pancreatobiliary region and their association with tumor-infiltrating neutrophils. Mod Pathol 18:1504\u20131511. https:\/\/doi.org\/10.1038\/modpathol.3800460","journal-title":"Mod Pathol"},{"key":"4681_CR43","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006565","author":"G Lionetto","year":"2026","unstructured":"Lionetto G, Mattiolo P, Ciulla C, Savegnago G, Casciani F, De Pastena M, Paiella S, Pea A, Esposito A, Crovetto A, Donadelli M, Franzina C, Fassan M, Scarpa A, Salvia R, Malleo G, Luchini C (2026) Morphologic characterization of pancreatic ductal adenocarcinoma following post-neoadjuvant pancreatectomy and clinical value of intratumor heterogeneity. Ann Surg. https:\/\/doi.org\/10.1097\/SLA.0000000000006565","journal-title":"Ann Surg"},{"key":"4681_CR44","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1245\/s10434-025-19051-5","volume":"33","author":"JM Ramia","year":"2026","unstructured":"Ramia JM, Villodre C, Giakoustidis D, Chatzikomnitsa P, Addeo P, Bachellier P, Nappo G, Zerbi A, Navez J, Blanco-Fern\u00e1ndez G, Kirkeg\u00e5rd J, Busquets J, Bj\u00f6rnsson B, S\u00e1nchez-Cab\u00fas S, Pando E, Staubli SM, Pandanaboyana S et al (2026) Adenosquamous carcinoma of the pancreas: outcomes of a multicenter european study (ADESQUPAN Project). Ann Surg Oncol 33:4072\u20134081. https:\/\/doi.org\/10.1245\/s10434-025-19051-5","journal-title":"Ann Surg Oncol"},{"key":"4681_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/path.4943","volume":"243","author":"Y Fang","year":"2017","unstructured":"Fang Y, Su Z, Xie J, Xue R, Ma Q, Li Y, Zhao Y, Song Z, Lu X, Li H, Peng C, Bai F, Shen B (2017) Genomic signatures of pancreatic adenosquamous carcinoma (PASC). J Pathol 243:155\u2013159. https:\/\/doi.org\/10.1002\/path.4943","journal-title":"J Pathol"},{"key":"4681_CR46","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nm.3548","volume":"20","author":"C Liu","year":"2014","unstructured":"Liu C, Karam R, Zhou Y, Su F, Ji Y, Li G, Xu G, Lu L, Wang C, Song M, Zhu J, Wang Y, Zhao Y, Foo WC, Zuo M, Valasek MA, Javle M, Wilkinson MF, Lu Y (2014) The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma. Nat Med 20:596\u2013598. https:\/\/doi.org\/10.1038\/nm.3548","journal-title":"Nat Med"},{"key":"4681_CR47","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.prp.2018.10.006","volume":"214","author":"M Tanigawa","year":"2018","unstructured":"Tanigawa M, Naito Y, Akiba J, Kawahara A, Okabe Y, Ishida Y, Ishikawa H, Hisaka T, Fujita F, Yasunaga M et al (2018) PD-L1 expression in pancreatic adenosquamous carcinoma: PD-L1 expression is limited to the squamous component. Pathol Res Pract 214:2069\u20132074. https:\/\/doi.org\/10.1016\/j.prp.2018.10.006","journal-title":"Pathol Res Pract"},{"key":"4681_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041398","volume":"12","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Xiong Q, Xu Y, Cai X, Zhang L, Zhu Q (2023) The PD-L1 expression and tumor-infiltrating immune cells predict an unfavorable prognosis in pancreatic ductal adenocarcinoma and adenosquamous carcinoma. J Clin Med 12:1398. https:\/\/doi.org\/10.3390\/jcm12041398","journal-title":"J Clin Med"},{"key":"4681_CR49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/PAS.0000000000002513","volume":"50","author":"D Atasoy","year":"2026","unstructured":"Atasoy D, Saka B, Armutlu A, Mericoz CA, Bagci P, Balci S, Tezcan N, Bakkaloglu IG, Altinmakas E, Bozkurt E, Pehlivanoglu B, Bozkurtlar E et al (2026) Metatypic carcinoma of the pancreas: delineation of a clinicopathologically distinct entity, characterized by centrally necrotic demarcated high-grade carcinoma with divergent patterns, basal immunophenotype, and altered molecular profile. Am J Surg Pathol 50:393\u2013405. https:\/\/doi.org\/10.1097\/PAS.0000000000002513","journal-title":"Am J Surg Pathol"},{"key":"4681_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2020.151583","volume":"48","author":"CE Hagen","year":"2020","unstructured":"Hagen CE, Christians K, Hopp A, Giorgadze T, Hartley CP, Hunt B, Basturk O, Klimstra D (2020) Intraductal papillary squamous neoplasm of the pancreas: cyto-histologic correlation of a novel entity. Ann Diagn Pathol 48:151583. https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151583","journal-title":"Ann Diagn Pathol"},{"key":"4681_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2026.101011","volume":"39","author":"M Bevere","year":"2026","unstructured":"Bevere M, Pea A, Adsay V, Basturk O, Brosens LA, Esposito I, Hruban RH, Klimstra D, Hong SM, Singhi AD, Lee SS, Mattiolo P, Pasini D, Mafficini A, Piccoli P et al (2026) Intraductal papillary squamous neoplasm (IPSN) of the pancreas: histological and molecular characterization of a novel and distinct intraductal cancer precursor. Mod Pathol 39:101011. https:\/\/doi.org\/10.1016\/j.modpat.2026.101011","journal-title":"Mod Pathol"},{"key":"4681_CR52","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/00000478-200305000-00002","volume":"27","author":"NV Adsay","year":"2003","unstructured":"Adsay NV, Merati K, Nassar H, Shia J, Sarkar F, Pierson CR, Cheng JD, Visscher DW, Hruban RH, Klimstra DS (2003) Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol 27:571\u2013578. https:\/\/doi.org\/10.1097\/00000478-200305000-00002","journal-title":"Am J Surg Pathol"},{"key":"4681_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00000478-200101000-00003","volume":"25","author":"NV Adsay","year":"2001","unstructured":"Adsay NV, Pierson C, Sarkar F, Abrams J, Weaver D, Conlon KC, Brennan MF, Klimstra DS (2001) Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 25:26\u201342. https:\/\/doi.org\/10.1097\/00000478-200101000-00003","journal-title":"Am J Surg Pathol"},{"key":"4681_CR54","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1136\/gutjnl-2017-315062","volume":"67","author":"M Felsenstein","year":"2018","unstructured":"Felsenstein M, No\u00eb M, Masica DL, Hosoda W, Chianchiano P, Fischer CG, Lionheart G, Brosens LAA, Pea A, Yu J, Gemenetzis G, Groot VP, Makary MA, He J, Weiss MJ, Cameron JL, Wolfgang CL, Hruban RH, Roberts NJ, Karchin R, Goggins MG, Wood LD (2018) IPMNs with co-occurring invasive cancers: neighbours but not always relatives. Gut 67:1652\u20131662. https:\/\/doi.org\/10.1136\/gutjnl-2017-315062","journal-title":"Gut"},{"key":"4681_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100554","volume":"37","author":"G Paolino","year":"2024","unstructured":"Paolino G, Basturk O, Esposito I, Hong SM, Brosens LA, Tarcan Z, Wood LD, Gkountakos A, Omori Y, Mattiolo P, Ciulla C, Marchegiani G, Pea A, Bevere M, De Robertis R, D\u2019Onofrio M, Salvia R, Cheng L, Furukawa T, Scarpa A, Adsay V, Luchini C (2024) Comprehensive characterization of intraductal oncocytic papillary neoplasm of the pancreas: a systematic and critical review. Mod Pathol 37:100554. https:\/\/doi.org\/10.1016\/j.modpat.2024.100554","journal-title":"Mod Pathol"},{"key":"4681_CR56","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/PAS.0000000000001226","volume":"43","author":"T Wang","year":"2019","unstructured":"Wang T, Askan G, Adsay V, Allen P, Jarnagin WR, Memis B, Sigel C, Seven IE, Klimstra DS, Basturk O (2019) Intraductal Oncocytic Papillary Neoplasms: Clinical-Pathologic Characterization of 24 Cases, With An Emphasis on Associated Invasive Carcinomas. Am J Surg Pathol 43:656\u2013661. https:\/\/doi.org\/10.1097\/PAS.0000000000001226","journal-title":"Am J Surg Pathol"},{"key":"4681_CR57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/gutjnl-2020-320726","volume":"70","author":"C Luchini","year":"2021","unstructured":"Luchini C, Brosens LAA, Wood LD, Chatterjee D, Shin JI, Sciammarella C, Fiadone G, Malleo G, Salvia R, Kryklyva V, Piredda ML, Cheng L, Lawlor RT, Adsay V, Scarpa A (2021) Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications. Gut 70:148\u2013156. https:\/\/doi.org\/10.1136\/gutjnl-2020-320726","journal-title":"Gut"},{"key":"4681_CR58","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.humpath.2022.06.009","volume":"132","author":"C Luchini","year":"2023","unstructured":"Luchini C, Scarpa A (2023) Microsatellite instability in pancreatic and ampullary carcinomas: histology, molecular pathology, and clinical implications. Hum Pathol 132:176\u2013182. https:\/\/doi.org\/10.1016\/j.humpath.2022.06.009","journal-title":"Hum Pathol"},{"key":"4681_CR59","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1038\/s41379-019-0317-6","volume":"32","author":"D Hutchings","year":"2019","unstructured":"Hutchings D, Jiang Z, Skaro M, Weiss MJ, Wolfgang CL, Makary MA, He J, Cameron JL, Zheng L, Klimstra DS, Brand RE, Singhi AD, Goggins M, Klein AP, Roberts NJ, Hruban RH (2019) Histomorphology of pancreatic cancer in patients with inherited ATM serine\/threonine kinase pathogenic variants. Mod Pathol 32:1806\u20131813. https:\/\/doi.org\/10.1038\/s41379-019-0317-6","journal-title":"Mod Pathol"},{"key":"4681_CR60","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s00423-024-03506-6","volume":"409","author":"A Bengtsson","year":"2024","unstructured":"Bengtsson A, Andersson R, Ansari D (2024) Histological variants of pancreatic ductal adenocarcinoma: a survival analysis. Langenbecks Arch Surg 409:312. https:\/\/doi.org\/10.1007\/s00423-024-03506-6","journal-title":"Langenbecks Arch Surg"},{"key":"4681_CR61","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0002-9440(10)65035-3","volume":"156","author":"RE Wilentz","year":"2000","unstructured":"Wilentz RE, Goggins M, Redston M, Marcus VA, Adsay NV, Sohn TA, Kadkol SS, Yeo CJ, Choti M, Zahurak M, Johnson K, Tascilar M, Offerhaus GJ, Hruban RH, Kern SE (2000) Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol 156:1641\u20131651. https:\/\/doi.org\/10.1016\/S0002-9440(10)65035-3","journal-title":"Am J Pathol"},{"key":"4681_CR62","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1136\/gutjnl-2020-320730","volume":"70","author":"RC Grant","year":"2021","unstructured":"Grant RC, Denroche R, Jang GH, Nowak KM, Zhang A, Borgida A, Holter S, Topham JT, Wilson J, Dodd A, Jang R, Prince R, Karasinska JM, Schaeffer DF, Wang Y, Zogopoulos G, Berry S, Simeone D, Renouf DJ, Notta F, O\u2019Kane G, Knox J, Fischer S, Gallinger S (2021) Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma. Gut 70:1894\u20131903. https:\/\/doi.org\/10.1136\/gutjnl-2020-320730","journal-title":"Gut"},{"key":"4681_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133119","volume":"13","author":"RT Lawlor","year":"2021","unstructured":"Lawlor RT, Mattiolo P, Mafficini A, Hong SM, Piredda ML, Taormina SV, Malleo G, Marchegiani G, Pea A, Salvia R, Kryklyva V, Shin JI, Brosens LA, Milella M, Scarpa A, Luchini C (2021) Tumor mutational burden as a potential biomarker for immunotherapy in pancreatic cancer: systematic review and still-open questions. Cancers (Basel) 13:3119. https:\/\/doi.org\/10.3390\/cancers13133119","journal-title":"Cancers (Basel)"},{"key":"4681_CR64","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1001\/jamaoncol.2024.3651","volume":"10","author":"CA O\u2019Connor","year":"2024","unstructured":"O\u2019Connor CA, Harrold E, Lin D, Walch H, Gazzo A, Ranganathan M, Kane S, Keane F, Schoenfeld J, Moss D, Thurtle-Schmidt DM, Suehnholz SP, Chakravarty D, Balogun F, Varghese A, Yu K, Kelsen D, Latham A, Weigelt B, Park W, Stadler Z, O\u2019Reilly EM (2024) Lynch syndrome and somatic mismatch repair variants in pancreas cancer. JAMA Oncol 10:1511\u20131518. https:\/\/doi.org\/10.1001\/jamaoncol.2024.3651","journal-title":"JAMA Oncol"},{"key":"4681_CR65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.humpath.2022.06.011","volume":"132","author":"P Mattiolo","year":"2023","unstructured":"Mattiolo P, Scarpa A, Luchini C (2023) Hepatoid tumors of the gastrointestinal\/pancreatobiliary district: morphology, immunohistochemistry, and molecular profiles. Hum Pathol 132:169\u2013175. https:\/\/doi.org\/10.1016\/j.humpath.2022.06.011","journal-title":"Hum Pathol"},{"key":"4681_CR66","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.humpath.2021.09.006","volume":"118","author":"RT Lawlor","year":"2021","unstructured":"Lawlor RT, Mafficini A, Sciammarella C, Cant\u00f9 C, Rusev BC, Piredda ML, Antonello D, Grimaldi S, Bonizzato G, Sperandio N, Marchegiani G, Malleo G et al (2021) Genomic characterization of hepatoid tumors: context matters. Hum Pathol 118:30\u201341. https:\/\/doi.org\/10.1016\/j.humpath.2021.09.006","journal-title":"Hum Pathol"},{"key":"4681_CR67","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12022-020-09628-z","volume":"31","author":"Y Xue","year":"2020","unstructured":"Xue Y, Reid MD, Pehlivanoglu B, Obeng RC, Jiang H, Memis B, Lui SK, Sarmiento J, Kooby D, Maithel SK, El-Rayes B, Basturk O, Adsay V (2020) Morphologic variants of pancreatic neuroendocrine tumors: clinicopathologic analysis and prognostic stratification. Endocr Pathol 31:239\u2013253. https:\/\/doi.org\/10.1007\/s12022-020-09628-z","journal-title":"Endocr Pathol"},{"key":"4681_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00428-022-03317-4","volume":"481","author":"P Mattiolo","year":"2022","unstructured":"Mattiolo P, Mafficini A, Lawlor RT, Marchegiani G, Malleo G, Pea A, Salvia R, Piccoli P, Sciammarella C, Santonicco N, Parisi A, Silvestris N, Milella M, Adsay V, Scarpa A, Luchini C (2022) \u201cPure\u201d hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms. Virchows Arch 481:41\u201347. https:\/\/doi.org\/10.1007\/s00428-022-03317-4","journal-title":"Virchows Arch"},{"key":"4681_CR69","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1158\/1078-0432.CCR-07-0487","volume":"14","author":"JM Winter","year":"2008","unstructured":"Winter JM, Ting AH, Vilardell F, Gallmeier E, Baylin SB, Hruban RH, Kern SE, Iacobuzio-Donahue CA (2008) Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer. Clin Cancer Res 14:412\u2013418. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-0487","journal-title":"Clin Cancer Res"},{"key":"4681_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100251","volume":"36","author":"M Simbolo","year":"2023","unstructured":"Simbolo M, Silvestris N, Malleo G, Mafficini A, Maggino L, Cocomazzi A, Veghini L, Mombello A, Pezzini F, Sereni E, Martelli FM, Gkountakos A, Ciaparrone C, Piredda ML, Ingravallo G et al (2023) Clinical and genomic characterization of pancreatic ductal adenocarcinoma with signet-ring\/poorly cohesive cells. Mod Pathol 36:100251. https:\/\/doi.org\/10.1016\/j.modpat.2023.100251","journal-title":"Mod Pathol"},{"key":"4681_CR71","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/ijc.34680","volume":"153","author":"R Morisue","year":"2023","unstructured":"Morisue R, Kojima M, Suzuki T, Watanabe R, Sakamoto N, Sakashita S, Harada K, Nakai T, Ishii G, Nakatsura T, Gotohda N, Ishikawa S (2023) Common clinicopathological and immunological features of sarcomatoid carcinoma across organs: A histomorphology-based cross-organ study. Int J Cancer 153:1997\u20132010. https:\/\/doi.org\/10.1002\/ijc.34680","journal-title":"Int J Cancer"},{"key":"4681_CR72","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.humpath.2022.07.011","volume":"128","author":"A Gkountakos","year":"2022","unstructured":"Gkountakos A, Mafficini A, Lou E, Malleo G, Salvia R, Calicchia M, Silvestris N, Racila E, Amin K, Veronese N, Brunetti O, Antonini P, Ingravallo G, Mattiolo P et al (2022) Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas. Hum Pathol 128:124\u2013133. https:\/\/doi.org\/10.1016\/j.humpath.2022.07.011","journal-title":"Hum Pathol"},{"key":"4681_CR73","doi-asserted-by":"publisher","DOI":"10.1200\/PO.23.00595","author":"EB Faber","year":"2024","unstructured":"Faber EB, Krause HB, Amin K, Walker P, Hosein PJ, Shields AF, Lenz HJ, Prakash A, Goel S, Oberley M, Malleo G, Luchini C, Hwang J, Florou V, Garrido-Laguna I, Lou E (2024) Genomic profiling of rare undifferentiated sarcomatoid subtypes of pancreatic carcinomas: in search of therapeutic targets. JCO Precis Oncol. https:\/\/doi.org\/10.1200\/PO.23.00595","journal-title":"JCO Precis Oncol"},{"key":"4681_CR74","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/modpathol.2014.100","volume":"28","author":"A Agaimy","year":"2015","unstructured":"Agaimy A, Haller F, Frohnauer J, Schaefer IM, Str\u00f6bel P, Hartmann A, Stoehr R, Kl\u00f6ppel G (2015) Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes. Mod Pathol 28:248\u2013260. https:\/\/doi.org\/10.1038\/modpathol.2014.100","journal-title":"Mod Pathol"},{"key":"4681_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100585","volume":"37","author":"A Yavas","year":"2024","unstructured":"Yavas A, Ozcan K, Adsay NV, Balci S, Tarcan ZC, Hechtman JF, Luchini C, Scarpa A, Lawlor RT, Mafficini A, Reid MD, Xue Y, Yang Z, Haye K, Bellizzi AM, Vanoli A, Benhamida J, Balachandran V, Jarnagin W, Park W, O\u2019Reilly EM, Klimstra DS, Basturk O (2024) SWI\/SNF complex-deficient undifferentiated carcinoma of the pancreas: clinicopathologic and genomic analysis. Mod Pathol 37:100585. https:\/\/doi.org\/10.1016\/j.modpat.2024.100585","journal-title":"Mod Pathol"},{"key":"4681_CR76","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/PAS.0000000000000689","volume":"40","author":"T Muraki","year":"2016","unstructured":"Muraki T, Reid MD, Basturk O, Jang KT, Bedolla G, Bagci P, Mittal P, Memis B, Katabi N, Bandyopadhyay S, Sarmiento JM, Krasinskas A, Klimstra DS, Adsay V (2016) Undifferentiated carcinoma with osteoclastic giant cells of the pancreas: clinicopathologic analysis of 38 cases highlights a more protracted clinical course than currently appreciated. Am J Surg Pathol 40:1203\u20131216. https:\/\/doi.org\/10.1097\/PAS.0000000000000689","journal-title":"Am J Surg Pathol"},{"key":"4681_CR77","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/path.4941","volume":"243","author":"C Luchini","year":"2017","unstructured":"Luchini C, Pea A, Lionheart G, Mafficini A, Nottegar A, Veronese N, Chianchiano P, Brosens LA, No\u00eb M, Offerhaus GJA, Yonescu R, Ning Y, Malleo G, Riva G, Piccoli P, Cataldo I, Capelli P, Zamboni G, Scarpa A, Wood LD (2017) Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma. J Pathol 243:148\u2013154. https:\/\/doi.org\/10.1002\/path.4941","journal-title":"J Pathol"},{"key":"4681_CR78","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00428-020-02830-8","volume":"477","author":"J Hrudka","year":"2020","unstructured":"Hrudka J, Lawrie K, Waldauf P, Ciprov\u00e1 V, Moravcov\u00e1 J, Mat\u011bj R (2020) Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: study of 13 cases comparing ductal pancreatic carcinoma and review of the literature. Virchows Arch 477:687\u2013696. https:\/\/doi.org\/10.1007\/s00428-020-02830-8","journal-title":"Virchows Arch"},{"key":"4681_CR79","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.humpath.2018.07.006","volume":"81","author":"C Luchini","year":"2018","unstructured":"Luchini C, Cros J, Pea A, Pilati C, Veronese N, Rusev B, Capelli P, Mafficini A, Nottegar A, Brosens LAA, No\u00eb M, Offerhaus GJA, Chianchiano P, Riva G, Piccoli P, Parolini C, Malleo G, Lawlor RT, Corbo V, Sperandio N, Barbareschi M, Fassan M, Cheng L, Wood LD, Scarpa A (2018) PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications. Hum Pathol 81:157\u2013165. https:\/\/doi.org\/10.1016\/j.humpath.2018.07.006","journal-title":"Hum Pathol"},{"key":"4681_CR80","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/his.15190","volume":"85","author":"MB Holm","year":"2024","unstructured":"Holm MB, Lenggenhager D, Detlefsen S, S\u00e1ntha P, Verbeke CS (2024) Identification of tumour regression in neoadjuvantly treated pancreatic cancer is based on divergent and nonspecific criteria. Histopathology 85:171\u2013181. https:\/\/doi.org\/10.1111\/his.15190","journal-title":"Histopathology"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04681-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04681-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04681-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T05:16:47Z","timestamp":1787375807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04681-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":80,"alternative-id":["4681"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04681-1","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"10 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable (review).","order":1,"name":"Ethics","label":"Ethics statement and Patient consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.L. is an Associate Editor of Virchows Archiv. C.L. reports honoraria from Astellas (consulting, steering committee), Bayer, Gilead sciences, MSD, and Medica s.r.l. (consulting and speaker bureau).","order":2,"name":"Ethics","label":"<b>Competing interests<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}]}}